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Haematopoietic ESL-1 enables stem cell
proliferation in the bone marrow by limiting
TGFb availability
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The life-long maintenance of haematopoietic stem and progenitor cells (HSPCs) critically
relies on environmental signals produced by cells that constitute the haematopoietic niche.
Here we report a cell-intrinsic mechanism whereby haematopoietic cells limit proliferation
within the bone marrow, and show that this pathway is repressed by E-selectin ligand 1
(ESL-1). Mice deficient in ESL-1 display aberrant HSPC quiescence, expansion of the immature
pool and reduction in niche size. Remarkably, the traits were transplantable and dominant
when mutant and wild-type precursors coexisted in the same environment, but were
independent of E-selectin, the vascular receptor for ESL-1. Instead, quiescence is generated by
unrestrained production of the cytokine TGFb by mutant HSPC, and in vivo or in vitro blockade
of the cytokine completely restores the homeostatic properties of the haematopoietic niche.
These findings reveal that haematopoietic cells, including the more primitive compartment,
can actively shape their own environment.
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Q
uiescence, an essential feature of haematopoietic stem
cells (HSCs), is thought to prevent exhaustion of the most
primitive compartment and to ensure protection from
environmental stress and DNA-damaging agents1. Imaging and
computational analyses have revealed that mesenchymal
perivascular cells around bone marrow (BM) arterioles promote
cycle arrest on HSC2. These arteriolar niches are in turn
innervated by nerves ensheathed by Schawnn cells, which also
contribute to cycle arrest and preservation of HSC in vivo3.
To preserve a homeostatic balance, however, the environment
must also provide HSC with proliferative signals. Among niche
cells, endothelial cells promote HSC proliferation through
E-selectin4. Whether proliferative regulation can also originate
from non-stromal cells, including haematopoietic cells that are an
integral part of the BM niche, remains an outstanding question.
HSC, which by definition are located within the niche, can
produce cytokines that impact their own proliferation and
differentiation5. Among these cytokines, transforming growth
factor b (TGFb) has been implicated in the regulation of
haematopoietic stem and progenitor cell (HSPC) cycling by
inhibiting lipid raft clustering and cytokine signalling6. The
impact of this cytokine for the in vivo maintenance of HSC is
highlighted by the loss of both quiescence and function of HSC
lacking the TGFb receptor II, or by analysis of animals in which
TGFb-producing Schwann cells were eliminated by sympathetic
denervation3. Defining the mechanisms that regulate TGFb
production is therefore essential to understand how
maintenance of HSPC in ensured in vivo.
In this study, while searching for the ligand responsible for
relaying the proliferative signals that emerge from vascular-borne
E-selectin on HSPC, we found that the absence of E-selectin
ligand 1 (ESL-1), a major ligand for E-selectin on haematopoietic
cells7, results in global quiescence in the primitive haematopoietic
compartment. Unexpectedly, we show that ESL-1 maintains
homeostatic proliferation within the BM not by engaging
E-selectin, but by repressing the production of TGFb by
haematopoietic cells, including HSPC.
Results
ESL-1-deficiency causes HSPC quiescence and expansion.
E-selectin expressed by vascular cells induces homeostatic
proliferation of HSC by signalling through unknown receptor(s)
on haematopoietic precursors that are distinct from its canonical
ligands PSGL-1 and CD44 (ref. 4). We hypothesized that ESL-1
could be endowed with the capacity of transducing the
proliferative signals from the BM vasculature because it is a
dominant E-selectin ligand of haematopoietic progenitors, in
which it promotes homing to the BM7. Indeed, we could detect
abundant ESL-1 transcript and protein in phenotypically
immature HSPC (Supplementary Fig. 1a,b), suggesting that
ESL-1 might be functionally relevant in the most primitive
haematopoietic compartment.
To test the possibility that ESL-1 promoted HSPC prolifera-
tion, we measured cycling of haematopoietic precursors in mice
deficient in ESl-1 (Glg1 / )8 and heterozygous littermates using
5-bromodeoxyuridine (BrdU) incorporation assays. Glg1 /
mutants displayed reductions in the frequencies of proliferating
LineageNEG cKitHI Sca1þ (LSK) cells and the more primitive LSK
CD48NEG and LSK CD48NEGCD150þ precursors (Fig. 1a). We
obtained independent confirmation of a reduced frequency of
cycling Glg1 / LSK CD48NEGCD150þ precursors by staining
for Ki67, a nuclear marker of cell cycling (Supplementary Fig. 1c).
In parallel to cycle arrest, we found an increase in the frequency
of myeloid progenitors (LineageNEG cKitHI Sca1NEG; MPs) and
LSK cells, as well as in primitive LSK CD135NEGCD90þ cells
(LT-HSC) in these mutants (Fig. 1b). Contrasting with the
expansion of immature precursors, we did not find increased
numbers of mature myeloid cells in the BM of ESL-1-deficient
mice, with the exception of resident macrophages which were
expanded (Supplementary Fig. 2a). Blood leukocyte counts were
slightly elevated but normal for erythrocyte and platelet numbers,
and the mice presented a mild splenomegaly (Supplementary
Fig. 2b). Collectively, these data indicated that ESL-1 controls
HSPC cycling and numbers, suggesting that ESL-1 might be the
E-selectin ligand responsible for transducing proliferative signals
in vivo.
Quiescence of Glg1 / HSPC is transplantable and dominant.
We reasoned that if ESL-1 triggered HSPC proliferation by
engaging E-selectin, then reconstitution of Glg1 / haemato-
poiesis into WT recipient mice should recapitulate the phenotype
of the full mutants. If this was the case, these haematopoietic
chimeras would also allow a more thorough examination of
mutant HSPC given the extremely low birth rate of Glg1 /
mice (o2% of the 25% expected from heterozygous breeders)7.
WT mice reconstituted with Glg1 / donor cells recovered well,
with blood counts and splenomegaly similar to full mutants, and
BM cellularity similar to mice transplanted with WT donors
(Supplementary Fig. 2c). As predicted, mice reconstituted with
mutant cells reproduced the marked reductions in proliferating
LSK and MP cells (Fig. 1c), as well as primitive LSK CD48NEG
and LSK CD48NEGCD150þ cells (Fig. 1d); in contrast, mice
deficient in a different E-selectin ligand, PSGL-1 (Selplg / ),
only displayed mild reductions in proliferation that were
restricted to LSK cells (Fig. 1c). Importantly, mice reconstituted
from Glg1 / donors also displayed increased quiescence as
shown by reductions in Ki67 staining in LSK cells
(Supplementary Fig. 2d) and increased number of surviving
reconstituting HSPC after hydroxyurea treatment (B4-fold
increase) that was markedly higher than that seen in untreated
mice (Supplementary Fig. 2e). Transplanted mice reproduced the
expansion in Glg1 / mice of primitive progenitors (Fig. 1e),
including a B2.5-fold increase in the number of functional HSC
as assessed by long-term reconstitution using limiting dilution
assays (Supplementary Fig. 2f). The dramatic increase in Glg1 /
repopulating units in the hydroxyurea suicide assay over the wild-
type (WT) group confirmed elevated quiescence of mutant HSPC
even if the starting number of progenitors was higher in mice
reconstituted with Glg1 / BM cells. To test the functional
consequence of quiescence in Glg1 / progenitors, we induced
haematopoietic exhaustion by repeated administration of the
chemotherapeutic agent 5-fluorouracil (5-FU). Although the
majority of mice reconstituted from WT donors succumbed by
8 weeks, mice transplanted with Glg1 / marrow showed a
dramatic resistance to exhaustion and death (Fig. 1f). These
results provide functional support to the observation that ESL-1
promotes homeostatic proliferation of HSPC.
To delineate whether the phenotype was cell-autonomous as
predicted by our model, we co-transplanted WT (expressing the
DsRed reporter gene) together with Glg1 / BM cells into WT
recipients, and after 8 weeks analysed HSPC proliferation
(Fig. 2a). Unexpectedly, not only ESL-1-deficient progenitors
displayed the expected reductions in proliferation, but WT
progenitors sharing the same host as Glg1 / mutants displayed
identical reductions, which were not seen when the
co-transplanted cells were of WT origin (Fig. 2b,c). These
observations indicated that the proliferative phenotype of
ESL-1-deficient haematopoietic precursors was transplantable,
and that ESL-1 cells transferred their proliferative trait to
genetically normal HSPC that share the same microenvironment.
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Elevated TGFb triggers quiescence in the absence of ESL-1. The
dominant phenotype of Glg1 / mutants indicated that
E-selectin-derived signals could not fully account for the pro-
liferative arrest. We thus searched for alternative mechanisms for
this unexpected phenotype. ESL-1 has been shown to limit the
maturation and secretion in chondrocytes of TGBb8, a cytokine
with potent anti-proliferative effects on HSC9,10. We thus tested
whether abnormal TGFb signalling might account for the
proliferative arrest observed in the absence of ESL-1. In
agreement with this possibility, TGFb protein levels were
elevated in mice reconstituted with Glg1 / marrow, as well
as in full Glg1 / mutants (Fig. 3a and Supplementary Fig. 3a),
and these elevations correlated with enhanced phosphorylation of
Smad2/3 in LSK cells (Fig. 3b and Supplementary Fig. 3b). In
addition, transcriptomic analyses of WT and mutant HSPC
revealed a pattern of expression of cycle inhibitory genes (Fig. 3c)
that was fully consistent with the temporal activation of the TGFb
signalling pathway in the context of BM regeneration11. To
determine whether elevated TGFb signalling was responsible for
HSPC quiescence in the absence of ESL-1, we treated mice
transplanted with mutant or WT BM with an anti-TGFb
antibody that efficiently blocks the cytokine in vivo12.
Inhibition of TGFb for 2 weeks resulted in restoration of HSPC
proliferation in Glg1 / mutants as measured by BrdU
incorporation and cell cycle analyses (Fig. 3d,e). Importantly,
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Figure 1 | ESL-1 controls the proliferation and numbers of HSPC in the bone marrow. (a) Representative plots of BrdU proliferation assays gated
on LineageNEG cKitHI Sca1þ (LSK) cells, LSK CD48NEG and LSK CD48NEG CD150þ cells in Glg1 / and Glg1WT/ littermates. Right, percentage of
BrdU-incorporating cells; n¼4. (b) Percentage of the indicated populations in the BM of Glg1 / and Glg1WT/ littermates; n¼ 5. (c) Experimental
design and percentage of BrdU incorporation in WT, Glg1 /and Selplg1 / progenitors in transplanted WT mice; n¼9–11. (d) Percentage of
BrdU-incorporating cells in the indicated HSPC populations from WT and Glg1 / -transplanted mice; n¼4. (e) Absolute numbers of the indicated
populations in two femurs of WT and Glg1 / transplanted mice; n¼ 7. (f) Survival curves of mice transplanted with WT or Glg1 / BM cells
after repeated injection of 5-FU; n¼ 10. *Po0.05; **Po0.01; ***Po0.005 as determined by Student’s t-test for two data sets, or one-way analysis
of variance with Turkey’s test for multiple data sets. In f, comparison of survivals was performed using the Log-rank test. Each circle represents a
mouse. Bars show mean±s.e.m.
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without affecting BM cellularity or other haematological
parameters, or the proliferative status of HSPC in WT cells
(Fig. 3d,e).
To test whether increased TGFb signalling in these mutants
could influence recovery under haematopoietic stress, we next
assessed the kinetics of haematopoietic regeneration after 5-FU
treatment in mice bearing WT or Glg1 / BM. We found a
delay in the recovery of circulating leukocytes and erythrocytes in
the absence of ESL-1 (unpaired t-test; Fig. 3g), and a similar trend
for platelet recovery (Supplementary Fig. 3c), which were in
agreement with the reduced proliferative rate in mutant BM. The
delayed recovery in Glg1 / mutants contrasted with their
enhanced resistance to repeated 5-FU treatment (Fig. 1f), which
was fully consistent with the notion that quiescence protects from
haematopoietic exhaustion upon chronic stress4. Interestingly,
the recovery delays became noticeable after day 10, a time when
elevated TGFb levels are known to return to baseline after 5-FU
treatment11, and blockade of TGFb normalized the recovery
kinetics of all blood parameters in the Glg1 / group
(Supplementary Fig. 3c). Thus, regulation of TGFb levels in
the BM is orchestrated by ESL-1, and this control preserves
homeostatic proliferation of HSPC and facilitates haematopoietic
recovery upon stress.
ESL-1 controls proliferation independently of E-selectin. Our
findings did not rule out a possible coordination between vascular
E-selectin and ESL-1 in inducing proliferation. We therefore
asked whether, in addition to regulating TGFb levels, ESL-1
controlled the distribution of HSPC through binding E-selectin
on sinusoidal vessels, as quiescence is favoured in distinct
perivascular regions of the marrow2. To address this possibility,
we examined the distribution of LinNEG CD48NEG CD150þ cells
or LinNEG cKitþ progenitors in the BM of mice reconstituted
with WT or Glg1 / donors (Fig. 4a,b and Supplementary
Fig. 4), and scored the distance between each progenitor and the
nearest vascular structure. We found that WT and Glg1 /
progenitors displayed identical distribution within the marrow
(Fig. 4a,b and Supplementary Fig. 4), indicating that alterations in
progenitor distribution were unlikely to account for the
proliferative defects of mutant mice.
To further examine whether E-selectin and ESL-1 functioned
along the same pathway to prevent quiescence, we generated
mixed chimeric mice using WT-DsRedþ and Glg1 / donors
that were co-transplanted into WT mice (Fig. 4c). Using this
approach, we generated two coexisting populations of HSPC
displaying similar proliferative defects (Fig. 2), in which we tested
the capacity of TGFb blockade to restore proliferation. If
E-selectin signalled through ESL-1, we predicted that this
treatment should rescue proliferation only in WT HSPC. TGFb
blockade, however, restored proliferation of both populations of
HSPC (Fig. 4c). In addition, blockade of TGFb in E-selectin-
deficient recipients (Supplementary Fig. 5) or blockade of both
E-selectin and TGFb in WT recipients (Fig. 4c) failed to restore
proliferation of WT or Glg1 / HSPC. These experiments
demonstrated that E-selectin and ESL-1 control proliferation
through different mechanisms.
Haematopoietic precursors are a relevant source of TGFb. The
transplantation experiments suggested that the elevations in
the levels of TGFb in the Glg1 / group originated from the
haematopoietic compartment. To search for the relevant source
of TGFb among haematopoietic cells, we measured ESL-1 protein
in multiple BM populations by western blot. Myeloid leukocytes
and immature progenitors displayed the highest levels of ESL-1
(Supplementary Fig. 6a). Because BM-resident macrophages were
expanded in Glg1 / mice (Supplementary Fig. 2a) and are a
potential source of TGFb13, we depleted these cells using
clodronate liposomes and measured the impact on HSPC
proliferation. Despite efficient depletion of macrophages
(Supplementary Fig. 6b), this treatment failed to restore HSPC
proliferation of Glg1 / HSPC (Fig. 5a), thus excluding these
cells as a relevant source of TGFb.
We then focused on immature haematopoietic precursors,
which also expressed high levels of intracellular ESL-1
(Supplementary Fig. 7a) and produce TGFb5. Given the lack of
tools for specific genetic or pharmacological manipulation of
HSPC in vivo, we performed ex vivo analyses. We first noticed
that Glg1 / marrow cells grown in semisolid cultures yielded
more CFU-C (Fig. 5b) that contained, however, less cells than
WT colonies (Supplementary Fig. 7b). Treatment with the
TGFbR-I inhibitor LY-2157299 reverted the cellularity of
Glg1 / colonies without affecting WT-derived CFU-C
(Supplementary Fig. 7b). Glg1 / cultures also yielded an
increase in the frequency of LinNEG cKitHI progenitors after 7
days of culture, which could also be reverted by the TGFbRI
inhibitor (one-way analysis of variance with Tukey’s multigroup
test; Fig. 5c), and replating assays resulted in elevated numbers of
secondary colonies, suggesting a higher self-renewal ability of
Glg1 / progenitors (Fig. 5d). We could reproduce these results





























































Figure 2 | Deficiency in haematopoietic ESL-1 generates a quiescent bone marrow environment. (a) Experimental scheme for the generation of mixed
chimeric mice by bone marrow transplantation. (b) Representative plots of BrdU incorporation in LSK and myeloid progenitors (MPs) in WT:WT-DsRed or
Glg1 / :WT DsRed chimeric mice. (c) Percentage of BrdU-incorporating WT-DsRed and Glg1 / cells in the mixed chimeric mice shown in b; n¼ 6.
NS, not significant. Each circle represents a mouse. Bar graphs show mean±s.e.m.
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reduced in Glg1 / cells and this could also be reverted
by blocking TGFb (Fig. 5e and Supplementary Fig. 7c), indicating
that early progenitors are an active source of inhibitory
TGFb. Importantly, and agreeing with the role of ESL-1 in
limiting posttranslational processing of pro-TGFb8, we did not
find changes in Tgfb1 transcript levels in mutant LSK cells
(Supplementary Fig. 8a), and in contrast found mild elevations in
the levels of latent TGFb on the surface of Glg1 / progenitors
compared with WT cells (Supplementary Fig. 8b).
Because Glg1 / cells induced quiescence on neighbouring
WT HSPC in vivo (Fig. 2), we sought to reproduce this
dominance in vitro using purified LSK cells. Mixed cultures of
WT and Glg1 / LSK cells resulted in reduced proliferation of
both types of progenitors, compared with mixtures of WT cells
only. Importantly, blockade of TGFb reversed the proliferative
defects of both WT and Glg1 / cells (Fig. 5f). Altogether, these
observations indicated that HSPC are a relevant source of TGFb,
which acts on neighbouring progenitors to block proliferation.
Haematopoietic ESL-1 maintains CXCL12-producing niche cells.



























































































































































































































Figure 3 | ESL-1 controls HSPC proliferation by repressing TGFb secretion. (a) TGFb levels in the BM of WT and Glg1 / -transplanted mice; n¼ 8.
(b) Micrographs of purified WT and Glg1 / LSK cells stained for pSMAD2/3 (red) and DAPI (blue). Scale bar, 5 mm. Data are from two independent
experiments. (c) Expression of p18, p21 and p57 in sort-purified WT and Glg1 / LSK cells; n¼6–8. (d) Representative contour plots of BrdU
incorporation in WT and Glg1 / LSK cells and MP treated with anti-TGFb or control antibody. Right, experimental design (top) and bar graphs (bottom)
show the percentage of BrdUþ cells in the different groups; n¼ 5. Each circle represents a mouse. (e) Representative plots and quantification of cell cycle
analyses of WT and Glg1 / LSK cells and MP from mice treated with anti-TGFb or control antibody; n¼6. (f) Absolute numbers of the indicated
progenitor populations in mice reconstituted with WT or Glg1 / marrow, and treated or not with anti-TGFb antibody; n¼ 5. (g) Recovery kinetics of
leukocytes (WBC) and erythrocytes (RBC) in the blood of mice reconstituted with WT or Glg1 / BM after treatment with a single dose of 5-FU; n¼ 10.
*Po0.05; **Po0.01; ***Po0.001 determined by Student’s test (a,g), Wilcoxon matched-pairs (c) or one-way analysis of variance with Turkey’s test
(d,e,f). Data are show as mean±s.e.m.
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from Glg1 / haematopoietic cells could affect the stromal
niche. To this end, we transplanted WT or Glg1 / donors into
Cxcl12GFP reporter mice, which allow identification of perivas-
cular cells expressing high levels of the chemokine (CD45NEG
CD31NEG GFPHI; CAR cells), as well as endothelial cells
(CD45NEG CD31þ GFPLO) and osteoblasts (CD45NEG
CD31NEG GFPLO)14,15. Imaging of sternal preparations revealed
reductions in CXCL12-producing cells in the Glg1 / group
(Fig. 6a), and this correlated with strong reductions in CXCL12
protein in the BM (Fig. 6b). Cytometric analyses revealed that
these reductions were associated with marked decreases in the
number of CAR and endothelial cells, but not osteoblasts
(Fig. 6c,d). Importantly, the reductions in CAR and endothelial
cells could be corrected by blocking TGFb (Fig. 6d), and
correlated with elevated TGFb-induced signalling in these two
cell types but not on osteoblasts (Supplementary Fig. 9a,b),
suggesting that this cytokine produced by ESL-1-deficient
haematopoietic cells can directly suppress the stromal niche, as
supported by previous reports16. Altogether, the data suggested
that haematopoietic-borne ESL-1 can control HSPC proliferation
directly through cytokine secretion, and/or indirectly through
repressive effects on supportive niche cells.
Discussion
Although the list of stromal constituents of the niche is being
rapidly refined17, only a handful of studies have focused on
haematopoietic cells as functional niche elements that regulate the
fate of the HSC from which they originate. In this study, we show
that haematopoietic progenitors have the capacity to regulate the
proliferative status of neighbouring HSPC through production of
TGFb and that this function is limited by ESL-1. Our findings
reveal that regulation of the niche can originate from
haematopoietic cells, including HSPC, and suggest that the
partnership of haematopoietic and mesenchymal stem cells that
are at the core of the BM niche18 allows mutual regulation of both
partners, as has been evidenced in leukaemic models19,20.
Besides HSPC, other haematopoietic cells including macro-
phages21,22 and megakaryocytes23,24 may be relevant sources of
TGFb and may thus regulate niche size and HSPC proliferation.
Although we have excluded macrophages as a major source,
perivascular megakaryocytes, which produce abundant TGFb24,
could also have a strong impact on the global levels of the
cytokine in the BM in the absence of ESL-1. Nonetheless, we
provide evidence that HSPC, which were shown in early in vitro
studies to be an autocrine source of TGFb25, can function as
regulators of their own environment. This finding is particularly
relevant because these cells are by definition the only population
unambiguously located within a haematopoietic niche.
An important extension from our study will be to uncover the
physiological or pathological scenarios in which the regulatory
restraint imposed by ESL-1 becomes inactive. As under
steady-state conditions blockade of the TGFb pathway does not
alter HSC proliferation (this study and11), we propose two
possible scenarios in which loss of this regulation may be relevant:































































Figure 4 | ESL-1 and E-selectin induce HSPC proliferation through independent mechanisms. (a) Representative images of the distribution of LinNEG
CD48NEG CD150þ cells in the BM relative to lamininHI (red) vessels; arrowheads indicate the position of a scored cell. Scale bars, 10mm. n¼ 7–9 mice,
55–70 cells per group. (b) Distances of LinNEG CD48NEG CD150þ cells to vessels in WT or Glg1 / BM. NS, not significant, as determined by Student’s
t-test. n¼ 39 or 40 cell per group. (c) Experimental design and percentage of BrdUþ LSK cells from each donor (WT-DsRed or Glg1 / ) in mixed
chimeric mice treated with isotype-matched, anti-TGFb alone or anti-TGFb plus anti-E-selectin antibodies. n¼ 5. Bars show mean±s.e.m. Each circle
represents a mouse. **Po0.01 by one-way analysis of variance with Turkey’s test comparing Glg1 /cells across the different groups; NS, not significant.
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myeloid bias and display delayed recovery from stress parallels
changes described in the aged haematopoietic system26.
Interestingly, alterations in TGFb signalling have been
associated with HSC ageing and are likely to underlie the
myeloid expansion in old animals27,28. An additional scenario,
pathological stress, is also of interest in light of recent work
showing that a transient wave of TGFb in the stressed marrow
prompts the return of HSC to quiescence after an initial
proliferative phase11, suggesting that pathways that regulate
TGFb signalling may be important for restoring haematopoietic
homeostasis. Both scenarios are currently being tested in our
laboratory.
The dominant effect that ESL-1 exerts on neighbouring HSPC
has implications for understanding the interactions of stem cells
within their niche. It suggests that deregulation of the pathway in
a single cell could initiate alterations in restricted populations of
HSPC and stromal cells that share a common ‘microniche’.
Whether clustering represents the normal distribution of
HSPC in vivo is unclear, but the recent identification of
hemospheres as units of clonal expansion29 supports this
possibility. Also noteworthy is the finding that subsets of
stromal niche cells associated with myeloid or the most
primitive precursors (endothelial and CAR cells17,30) appear
repressed in the absence of ESL-1, whereas osteoblasts that are
associated with the lymphoid lineage that expresses little ESL-1
remain largely unaffected, suggesting local regulation of the
various haematopoietic environments.
An unexpected finding from our study was that, although
ESL-1 has been shown to be a ligand for E-selectin on
haematopoietic progenitors7, each molecule (ESL-1 and
E-selectin) affects HSPC proliferation through independent
mechanisms. The predominant expression of ESL-1 inside the
cell rather than at the surface (which would be required for
selectin binding) is consistent with this independent mechanism.
Thus, the identity of the relevant E-selectin ligand(s) on HSPC
responsible for the proliferative effects remains unknown,
although it is possible that glycosphingolipids, or a combination
of various glycoproteins (as shown for the recruitment of
neutrophils31), cooperate for selectin binding and for cycle
arrest. This possibility is sustained by the growing appreciation
that a complex array of differentially glycosylated proteins
(and lipids) other than PSGL-1 and ESL-1 can function as
ligands for E-selectins on haematopoietic cells7,32. This important
issue deserves further study. In addition, although it has been
speculated that E-selectin might control HSPC by dictating their
distribution within the non-uniform BM microenvironment4, the
mechanism by which this selectin and its ligand(s) ultimately
regulate HSPC proliferation remains to be elucidated.
In summary, the identification of an intrinsic pathway
controlled by ESL-1 that regulates HSPC proliferation, but can
also impact the behaviour of neighbouring stromal cells and
HSPC (scheme in Supplementary Fig. 10), yields important
insights into how stem cell dynamics are regulated to maintain





































































































































































Figure 5 | Haematopoietic precursors are a relevant source of TGFb. (a) Percentage of BrdU incorporation in WT or Glg1 / LSK cells of control or
macrophage-depleted (Clod) mice; n¼ 5. (b) Frequency of the different types of CFU-C in mice reconstituted with WT or Glg1 / donors; n¼6.
(c) Contour plots (left) and frequency (right) of LinNEG cKitþ cells obtained from WT or Glg1 / marrow grown in the presence or absence of the TGFbRI
inhibitor LY-2157299; n¼6. (d) Number of secondary colonies after replating WT or Glg1 / CFU-C from primary cultures; n¼ 3 independent
experiments. (e) Relative in vitro proliferation of WT or Glg1 / LSK cells, as measured by BrdU incorporation; n¼ 3 independent experiments.
(f) Experimental design to test the in vitro proliferation of WT and Glg1 / LSK cells in co-cultures with or without TGFb blockade. Representative contour
plots (right) and quantification of the relative proliferation; n¼ 3 independent experiments. Data are shown as mean±s.e.m.; *Po0.05; **Po0.01;
***Po0.001; NS, not significant, as determined by Student’s t-test (b,d), or one-way analysis of variance with Turkey’s test (a,c,e and f).
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Methods
Mice. All experiments were performed in 6- to 10-week-old male mice housed
in a specific pathogen-free facility. ESL-1- (Glg1 / ), PSGL-1- (Selplg / ) and
E-selectin- (Sele / ) deficient mice were obtained from B. Lee (Baylor College of
Medicine, Houston, TX, USA) and P. Frenette (Einstein College of Medicine, NY,
USA), and have already been described8,33. Cxcl12-Gfp knock-in mice34 were also
used as recipients. Mice expressing DsRed under the b-actin promoter were used as
donors in some experiments. Wild-type C57BL/6 (CD45.2þ ) and congenic B6.SJL
(CD45.1þ ) mice were used as donors or recipients. All mice were in a pure
C57BL/6 background. Experimental procedures were approved by the Animal Care
and Ethics Committee at Fundación CNIC and Comunidad de Madrid.
Cell isolation. After euthanasia, femurs were collected and flushed into ice-cold PBS
plus 0.5% fetal bovine serum (FBS) for the isolation of BM cells. For estimation of
CXCL12-expressing niche cells, femurs were flushed and incubated with 1 U ml 1
liberase (Roche Applied Science) and 12 mU ml 1 DNase I (Sigma) in HBSS for
30 min at 37 C. Cells were sorted on a FACSAria (BD Biosciences) to 495% purity.
Flow cytometry. For BM mature myeloid compartment, cells were stained
with fluorescein isothiocyanate (FITC)-conjugated Gr-1 (Clone RB6-8C5),
PE-conjugated CD115 and Alexa Fluor 647-conjugated F4/80 (Clone CI:A3-1;
purchased from Serotec) antibodies in PBS containing 2 mM EDTA and 0.5% FBS.
For LSKs and MPs, cells were stained with biotinylated lineage antibody cocktail
(CD3e, B220, CD11b, Gr1 and Ter119) from BD Bioscience, together with
streptavidin conjugated to DyLight 405 (purchased from Jackson), antibody to
Sca-1 (Clone: D7) conjugated to FITC or antigen-presenting cell (APC) and
antibody to c-Kit (Clone: 2B8) conjugated to PE-Cy7. For the analyses of MPP,
ST-HSC and LT-HSC cells, samples were stained with the biotinylated lineage
antibody cocktail plus anti-Sca-1-FITC, anti-cKit-PE-Cy7, anti-CD135-PE
(Clone: A2F10) and anti-CD90.2-APC (Clone: 53-2.1). For HSC staining using the
SLAM markers, cells were stained with biotinylated lineage antibody cocktail and
biotinylated CD48 (Clone: HM48-1) together with streptavidin conjugated to Alexa
Fluor 405, and antibodies against Sca-1-APC, c-Kit-PE-Cy7 and CD150-PE (Clone:
TC15-12F12.2). CD48 and CD150 antibodies were purchased from BioLegend. All
other antibodies were purchased from eBioscience. For assessment of multilineage
chimerism, blood leukocytes were stained with PE-Cy7-conjugated CD45.1
(Clone A20), purchased from Southern Biotech, FITC-conjugated CD45.2
(Clone 104; TOMBO Bioscience), PE-conjugated CD11b (Clone M1/70;
eBioscience), APC-conjugated CD3e (Clone 145-2C11; BioLegend) and biotiny-
lated-B220 together with streptavidin conjugated to DyLight 405.
For BrdU staining of HSC, BM cells were first enriched by immunomagnetic
depletion using BD IMag kit (BD Bioscience). Lineage negative enriched cells were
stained with biotinylated CD48 together with streptavidin conjugated to Alexa Fluor
405, plus antibodies against Sca-1-APC, c-Kit-PE-Cy7 and CD150-PE. For BrdU
staining of LSK cells and MP, cells were directly stained as above. Stained cells were
then fixed and permeabilized using the Cytoperm/Cytofix kit (BD Biosciences) as per
the manufacturer’s instructions and incubated with DNAse I at 37 C for 1 h. Cells
were finally stained with anti-BrdU-APC before cytometric analysis.
For detection of Ki67 in LSK or SLAM progenitors, BM suspensions were
surface stained as above, fixed and permeabilized using the Mouse Foxp3 fixation
and permeabilization buffers (BD Biosciences), and then stained with an
anti-mouse Ki67 conjugated to Alexa600 (Clone: SolA15; eBioscience) and Hoechst
33342.
To analyse cell cycle on LSK cells and MP, live cells were surface stained with
the lineage antibody cocktail together with streptavidin conjugated to APC-Cy7,
plus antibodies against Sca-1-FITC and c-Kit-APC. Cells were then stained with
Hoechst 33342 (Invitrogen) at 37 C for 45 min. Pyronin Y (Sigma-Aldrich) was
then added at 1 mg ml 1, and the cells were incubated for another 15 min at 37 C,
washed and immediately analysed using a 561-nm excitation laser to prevent
bleeding into all other channels used for this staining.
CXCL12-expressing niche cells were analysed by staining digested BM
suspensions from Cxcl12GFP mice with biotinylated antibodies against TER-119
and CD45 (Clone: 30-F11; eBioscience) followed by incubation with streptavidin
conjugated to DyLight-405 and an anti-CD31-APC antibody (Clone: 390;
eBioscience). High or intermediate levels of GFP in the CD45/TER119/CD31-
negative fraction were used to discriminate CAR cells from the GFPLO osteoblastic
fraction.
To label latent TGFb associated with the cell surface, LSK cells were stained
with anti-LAP-APC (Clone: TW7-16B4) or isotype control conjugated to APC
(MOPC-21; both from BioLegend). All cytometric analyses were performed using a
LSR-Fortessa flow cytometer equipped with DIVA software (BD Biosciences). Data
were analysed with the DIVA or FlowJo (TreeStar Inc.) softwares. All experiments
were conducted at the CNIC-Cellomics Unit.
A list of all the antibodies used in this study and the dilutions at which they
were used is in Supplementary Table 1.
Generation of BM chimeras by transplantation. Donor BM cells were harvested
from the appropriate genotype (WT DsRed or experimental WT, PSGL-1- or
ESL-1-deficient mice) by flushing both tibiae and femora into PBS. Recipient WT
C57BL/6 mice were lethally irradiated (6.5 Gy split doses, 3 h apart) before
























































Figure 6 | Haematopoietic ESL-1 preserves the CXCL12-producing bone marrow stroma. (a) Whole-mount staining of sternal BM of Cxcl12GFP mice
transplanted with WT or Glg1 / bone marrow cells; n¼4. Scale bar, 50mm. (b) CXCL12 protein levels in the BM mice transplanted with WT or Glg1 /
bone marrow cells; n¼ 5. (c) Representative density plots showing osteoblasts (OB), CAR and endothelial cells (ECs) in the bone marrow of the BM of
Cxcl12GFP mice reconstituted with WT or Glg1 / BM, and treated or not with an anti-TGFb antibody for 2 weeks, and quantification of their relative
numbers (d); n¼ 5 mice per group. Data are shown as mean±s.e.m.; *Po0.05; **Po0.01; ***Po0.001 as determined by Student’s t-test (b), or one-way
analysis of variance with Turkey’s test (d).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10222
8 NATURE COMMUNICATIONS | 7:10222 | DOI: 10.1038/ncomms10222 | www.nature.com/naturecommunications
numbers of experimental and WT-Dsred BM cells (106þ 106 cells) were mixed and
injected into the same recipients. Engraftment of recipient animals was assessed at
least 8–10 weeks after transplantation by analysis of the percentage of KO and WT
Dsredþ cells in the blood by flow cytometry. This method ensured the exclusion of
variability owing to environmental factors and allowed comparing the behaviour of
mutant and WT competitor cells within the same physiological environments.
Competitive repopulation assays. 5,000, 25,000, 50,000 and 100,000 WT or
Glg1 / BM cells were injected together with 3 105 BM cells from B6.SJL
CD45.1þ mice into nine lethally irradiated CD45.1þ per dose. Multilineage
chimerism was determined in the blood 16 weeks after transplantation,
and mice were scored positive when donor contribution was 41%. The
frequency of repopulating cells was calculated using the ELDA software
(http://bioinf.wehi.edu.au/software/elda/)35. To assess the quiescence of HSC, we
treated WT and Glg1 / mice with the S phase-specific cytotoxic agent
hydroxyurea and harvested BM. The equivalent of 2% of one femur was mixed with
3 105 BM cells from B6.SJL untreated mice and transplanted into lethally
irradiates B6.SJL recipients. Lineage chimerism was measured at 16 weeks after
transplant. The number of CD45.2þ reconstitution units (RUs) injected per
recipient mouse was calculated using the formula (DC)/(100–D), where D is the
percentage of recipient blood leukocytes that are CD45.2þ at the 16-week test
bleed, and C the number of competing CD45.1þ RUs that were co-injected
(C¼ 3, meaning that 3 105 competing BM cells were injected). Reconstitution
units per femur were then calculated. One RU is defined as the HSC content in
1 105 BM cells36.
In vivo treatments. For proliferation assays, BrdU (Sigma) was administered at
0.5 mg ml 1 in drinking water. For HSC exhaustion experiments, 5-FU (Sigma)
was injected at 150 mg per kg body weight intraperitoneally (i.p.) once or every 10
days. For myelo-suppressive treatments, 5-FU was injected once (150 mg kg 1 i.p.).
To assess haematological recovery, peripheral blood (50ml) was collected into
EDTA-coated capillary tubes (Sarstedt), and differential counts were measured
using a Pentra 80 hematologic analyser (Horiba). To assess HSPC quiescence,
hydroxyurea (Sigma) was injected twice (8 h apart) at 900 mg per kg body weight
i.p. as described earlier4. For in vivo inhibition of TGFb, a neutralizing antibody
(clone 1D11) or a non-targeted control antibody (clone HRPN; both IgG1 from
BioXcell) were intravenously injected at 100mg per mouse once every 2 days for a
total of 2 weeks. To block E-selectin, mice were treated with the same doses as
above of an anti-E-selectin blocking antibody (clone 9A9; BioXcell) following the
same schedule. To deplete macrophages, mice were intravenously injected with
100ml of liposomes loaded with clodronate 8 days before analysis
(Clodronateliposomes.com).
Immunofluorescence. CXCL12-expressing niche cells and LSK cells sorted from
WT of Glg1 / transplanted mice were cytospun onto glass slides, immediately
fixed with 2% paraformaldehyde and permeabilized with cold methanol. After
blocking, cells were stained with anti-pSmad2/3 (Clone: D27-F4; Cell Signalling
Technology) or anti-ESL-1rabbit serum, and secondary antibody (goat anti-rabbit
Alexa Fluor 555 or Alexa Fluor 488, respectively; Invitrogen). Stained cells were
counterstained with 4,6-diamidino-2-phenylindole (DAPI) to reveal nuclei. LSK
cells images were collected using a Leica SP5 multi-line inverted confocal
microscope. CXCL12-expressing cells images were acquired with a Zeiss LSM 700
confocal system (Carl Zeiss MicroImaging).
BM imaging. Sterna from necropsies were fixed with 4% paraformaldehyde in PBS
at 4 C overnight. Sternal bones were decalcified for 2 weeks with 0.25 M EDTA
(fresh solution each 3 days) at 4 C with agitation. To avoid the formation of
crystals during the freezing, sterna were incubated with 30% sucrose in PBS for 2
days at 4 C. The specimens were fast frozen in OCT with ethanol/dry ice and
transected to obtain 2- to 3-mm fragments in a cryostat to expose the BM. BM
tissues were blocked overnight to prevent nonspecific binding and permeabilized
with TNB 0.1% Triton at 4 C with horizontal shacking. BM tissues were
then blocked 20 min to prevent endogenous biotin-sterptavidin conjugation
(streptavidin/biotin blocking kit, Vector Labs). After three washes with PBS, we
incubated with gently shaking at 4 C overnight with goat polyclonal anti-mouse
c-Kit antibody (R&D, AF1356, 1:100 dilution) or anti-mouse Collagen IV
(Millipore, AB756P, 1:200 dilution), plus the lineage biotynilated cocktail con-
taining anti-mouse Ly-6G/C-biotin (Clone RB6-8C6), anti-mouse TER-119/
Ly-76-biotin, anti-mouse CD45R (B220) biotin, anti-mouse CD3e-biotin, anti-
mouse CD11b/Mac-1-biotin diluted (all diluted 1:100 in PBS). After washing for
8 h under shaking with PBS plus 0.05% Triton (buffer changed each 2 h), the
samples were incubated with secondary antibodies (donkey anti-goat IgG-Cy3 at
1:200 dilution, streptavidin Dylight 649 at 1:500 dilution and donkey anti-rabbit
IgG-AF488 at 1:200 dilution) at 4 C overnight with gentle shaking. Samples were
then washed for 6 h with shaking as before with fresh buffer changed every 45 min,
plus one wash at 4 C with PBS for 10 min. Nuclei were stained using PBS-DAPI
(1:1,000 dilution) for 5 min at room temperature, and excess DAPI was removed
with a final wash with PBS for 10 min. The fluorescently labelled BM tissue within
bone fossae was placed cut-face down onto a 35-mm coverglass culture dish
(MatTek Corporation), in (50–100 ml) PBS to prevent desiccation. Fluorescence
images of as many as four colours were captured sequentially, using a 360-nm or
405-nm laser line and emission 385–470 nm for DAPI, a 488-nm laser line and
emission between 488 and 522 nm for Alexa Fluor 488, a 555-nm laser line and
emission between 555 and 585 nm for Cy3, and a 639-nm laser line and emission
between 639 and 669 nm for Dylight 649. Series of x–y–z images of typically
640 640mm2 x–y size were collected along the z-axis at 1- to 4-mm intervals to
B100- to 150-mm depths throughout the BM tissue, using a  10 objective.
Whole-mount sterna imaged as indicated were analysed using the Imaris software
(Bitplane; South Windsor) using built-in plugins to mask Collagen VI-bright
vessels. LineageNEG cKitHI progenitors were identified manually in each image and
distances to vessels determined using automated algorithms.
For SLAM progenitor staining, femurs from necropsies were fixed with 4%
paraformaldehyde in PBS at 4 C overnight. Femoral bones were prepared
and blocked as indicated above for sterna. The specimens were frozen in
2-methylbutane (Fisher Scientific), and cooled on dry ice, and 8-mm thick sections
were cut in a cryostat. Tissues slides were blocked 20 min to prevent nonspecific
binding and permeabilized with TNB 0.1% Triton at 4 C. After three washes with
PBS, we incubated at 4 C for 2 days with anti-mouse CD48 biotin (110410
BioLegend 1:200 dilution), purified anti-mouse CD150 (115902 BioLegend 1:50
dilution), the rat mAb Lineage biotynilated cocktail and a rabbit anti-laminin
antibody (L9393-2mL Sigma 1:200 dilution). After washing four times for 5 min
with PBS plus Triton 0.05%, the samples were incubated with secondary antibodies
(anti-rat IgG FITC (1/200 diluted), streptavidin 546 (1/100 diluted) and AlexaFluor
635 goat anti-rabbit (1/200 diluted)) at 4 C overnight. Samples were then washed
four times for 5 min. Nuclei were stained using Vectashield Mounting medium
with DAPI (H1200 VectorLabs). All images were acquired with a Zeiss LSM 700
confocal system (Carl Zeiss MicroImaging) and analysed using the Fiji software
with customized plugins.
Chemokine and cytokine quantification. CXCL12 was measured from total BM
extracellular fluid content obtained after flushing BM from femurs in 1 ml of PBS,
using commercially available ELISA reagents (R&D Systems). Samples were diluted
1:2 in PBS. Levels of active TGFb were quantified using Quantikine ELISA kit
(R&D Systems) following the manufacturer’s instructions. Samples were diluted
1:10 in PBS. For samples from Glg1 / mice, the values were corrected for the
reduced number of cells and marrow size of the mutant mice.
Western blotting. For western blot analyses, B and T lymphocytes from BM were
stained with biotinylated anti-B220 (Clone: RA3.3A1/6.1) and anti-CD3e-APC
(Clone: 145-2C11), respectively. Monocytes, neutrophils, macrophages, MP and
LSK were stained as described above. Cells were sorted and lysed in Laemmli’s
sample buffer with 50 mM dithiothreitol, and boiled for 5 min. The equivalent of
105 cells (for the myeloid compartment) or 1.5 105 cells (for lymphocytes) was
loaded onto each lane of a 7.5% SDS–PAGE gel and after electrophoresis the
separated proteins were blotted onto a nitrocellulose membrane (Millipore).
Membranes were blocked and incubated with an anti-ESL1-myc rabbit serum
(a gift of Dr M.K. Wild; 1:1,000 diluted) and then washed thrice. The primary
antibody was detected by using horseradish peroxidase (HRP)-conjugated
anti-rabbit IgG (GE Healthcare; 1:5,000 diluted). Membranes were incubated
with HRP substrate (Luminata Forte Western HRP substrate, Millipore) and
luminescence was recorded on an ImageQuant LAS 4000 mini system
(GE Healthcare). To obtain an internal load control, the membranes were then
stripped and re-blotted with an anti-b-actin antibody (Sigma; 1:2,500 diluted).
Progenitor assays in culture. BM were collected and 20,000 mononuclear cells
were added to semisolid media containing 1.25% methylcellulose (Sigma-Aldrich),
30% FBS (StemCell Technologies), 1% deionized bovine serum albumin, 10 4 M
2-mercaptoethanol and conditioned medium (12.7% v/v) from the WEHI3 cell line
(containing IL-3), HM-5 cell line (containing GM-CSF) and BHK/MKL cell line
stably transfected to produce the secreted form of murine Kit Ligand/SCF. In some
experiments, cells were plated in Methocult GF M3434 (StemCell Technologies)
for identification of different types of precursors in culture (colony-forming unit
granulocyte-macrophage (CFU-GM), colony-forming unit macrophage (CFU-M)
and colony-forming unit granulocyte (CFU-G); burst-forming unit erythroid
(BFU-E); colony-forming unit granulocyte, erythroid, macrophage and mega-
karyocyte (CFU-GEMM)). The TGFbR-I inhibitor LY-2157299 (kindly provided
by Eli Lilly; Indiana) was added at a concentration of 500 nM. Control cultures
were grown in the presence of dimethylsulphoxide (vehicle for the inhibitor).
Cultures were plated in duplicates in 35 mm culture dishes (Nunc A/S) and
incubated at 37 C in 5% CO2. CFU-C were scored on day 6 or 7 using an
inverted microscope.
In vitro culture. Sorted LSK were cultivated overnight in StemSpan medium
(Stem Cell Technologies) supplemented with 100 ng ml 1 rmTPO, 100 ng ml 1
rmFlt3 ligand, 50 ng ml 1 rmSCF, in the presence of anti-TGFb or control anti-
body at 10 mg ml 1. Subsequently, 10 mM BrdU was added to the cultures for 4 h,
and BrdU incorporation and cell surface phenotypes were analysed.
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RNA isolation and real-time quantitative PCR. BM LSKs were purified from
femurs and tibiae. Staining was performance as described above. Total RNA was
prepared with RNA Extraction RNeasy Plus Mini- or Micro-kit (Qiagen). RNA was
reverse-transcribed with High-Capacity cDNA Reverse Transcription reagents kit
(Applied Biosystems) according to the manufacturer’s protocol. Real-time quan-
titative PCR (SYBR-green, Applied Biosystems) assays were performed with an
Applied Biosystems 7900HT Fast Real-Time PCR System sequencer detector.
Expression was normalized to Hprt (F-50-CCTAAGATGAGCGCAAGTTGAA-30 ,
R-50-CCACAGGACTAGAACACCTGCTAA-30) and 36b4 (F-50-ACTGGTCTA
GGACCCGAGAAG-30, R-50-TCCCACCTTGTCTCCAGTCT-30) expression. The
primer sequences for Glg-1 were: F-50-CAAGATGACGGCCATCATTTT-30 ,
R-50-TTCCCCAAGACGAATGCTGC-30 ; for p18: F-50-TTATGAAGCACACA
GCCTGCAATGT-30 , R-50-ACGGACAGCCAACCAACTAACGG-30 ; for p21:
F-50-TGTCTTGCACTCTGGTGTCTGAGC-30, R-50-TCTTGCAGAAGAC
CAATCTGCG-30 ; for p57: F-50-GCGCAAACGTCTGAGATGAG-30 , R-50-AGA
GTTCTTCCATCGTCCGCT-30 ; for Tgfb1: F-50-CCGAAGCGGACTACTAT-30 ;
R-50-GTAACGCCAGGAATTGT-30 .
Statistical analyses. Data are shown as the meanþ s.e.m. For comparisons
between two groups the Student’s t-test was applied. For data with more than two
data sets, we used one-way analysis of variance with Turkey’s multigroup test.
Log-rank analysis was used for Kaplan–Meier survival curves. For the limiting
dilution LT-reconstitution assays, we used Poisson’s statistics as indicated.
Analyses were performed with the GraphPad Prism software. P valueso0.05 were
deemed significant.
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